What’s Happening With PFE Stock?
Pfizer stock (NYSE: PFE) is down 7% in a month, amid rising concerns over the future of vaccines under Robert F. Kennedy Jr. in the new government, given the perception of him being a prominent anti-vaccine activist. Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years. It has seen a 50% drop from levels of $52 seen in early 2022 to $26 now, compared to a 4% rise for the broader S&P 500 Healthcare index…
